CIA
SYRS

Capital Impact Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Capital Impact Advisors’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,860
Closed -$1.83M – 139
2020
Q4 		$1.83M Hold
16,860
– – 0.45% 87
2020
Q3 		$1.49M Buy
+16,860
New +$1.49M 0.44% 91